One of the growing trends in the medtech industry is the rapid adoption of remote patient monitoring/telehealth. Glooko’s latest financing round is an example of the impact of the growing trend.

With a shift to virtual/decentralized clinical trials, the popularity of decentralized clinical trials (DCTs) skyrocketed following the nationwide lockdown last March.

While the far-reaching effects of COVID-19 have introduced the world to a “new normal,” the greatest impact has been in healthcare. In the long term, it has forever shaped the future of healthcare delivery, while its immediate effect has been on medical technology.

In an interview with Medtech Insight, Glooko CEO Russ Johannesson outlines the company’s growth opportunities, expansion plans beyond diabetes and financing plans.

A group of major CRO, life science, data analytics, publishing and healthcare companies, including Glooko, joined forces to release a pro bono research database to build up and integrate a central hub on the latest data out for COVID-19.

US-based diabetes software app, Glooko has announced a partnership with the Association of British Clinical Diabetologists (ABCD) / Diabetes Technology Network (DTN), to launch an online medical education programme for clinicians who treat people with diabetes in the UK.

A leading diabetes software company is taking action to serve the global diabetes community amid the current COVID-19 pandemic and offering a free, remote care solution for healthcare professionals.

As America and the rest of the world grapples with the escalating global coronavirus pandemic of 2020, healthcare providers are transitioning to remote patient care — often on the fly. While hospitals are adopting emergency action plans.

Digital diabetes management company Glooko has announced the appointments of a new CCO and COO. The first role went to Zach Henderson, formerly of LexisNexis Health Care and Elsevier.

Glooko, a provider of diabetes data management solutions, announced the appointment of Mark Clements, MD, Ph.D., CPI, FAAP, as Chief Medical Officer. Dr. Clements joins the senior management team of Glooko having served on its medical advisory.